![aap Implantate AG: aap with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1) - MoneyController (ID 198801) aap Implantate AG: aap with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1) - MoneyController (ID 198801)](https://www.moneycontroller.co.uk/upload/aziende/aapimplantateag-20200225102031.png)
aap Implantate AG: aap with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1) - MoneyController (ID 198801)
![Interim Report 2019 2nd quarter Half-Year Report - aap Implantate - PDF Catalogs | Technical Documentation Interim Report 2019 2nd quarter Half-Year Report - aap Implantate - PDF Catalogs | Technical Documentation](https://img.medicalexpo.com/pdf/repository_me/67475/interim-report-2019-2nd-quarter-half-year-report-229004_1mg.jpg)
Interim Report 2019 2nd quarter Half-Year Report - aap Implantate - PDF Catalogs | Technical Documentation
![Orthopedic Devices Market See Incredible Growth 2022-2028 | aap Implantate AG, Aesculap, Inc., Arthrex, Inc., ArthroCare Corporation, Biomet, Inc., Conmed Corporation, DePuy Synthes, Inc., OSSIO, Globus Medical, Inc. | Medgadget Orthopedic Devices Market See Incredible Growth 2022-2028 | aap Implantate AG, Aesculap, Inc., Arthrex, Inc., ArthroCare Corporation, Biomet, Inc., Conmed Corporation, DePuy Synthes, Inc., OSSIO, Globus Medical, Inc. | Medgadget](https://www.medgadget.com/wp-content/uploads/2022/04/orthopedic-devices-market-scaled.jpg)